Merck - 48 Year Stock Price History | MRK

Historical daily share price chart and data for Merck since 1970 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Merck as of November 13, 2018 is 74.61.
Merck Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 62.1583 55.3006 75.4800 52.8219 74.6100 34.80%
2017 60.1397 57.3995 64.5251 52.7631 55.3498 -1.47%
2016 53.9407 48.5144 61.5216 44.9183 56.1781 15.05%
2015 51.3294 51.1537 56.3773 44.3698 48.8287 -3.87%
2014 50.3225 42.9485 54.9321 42.9485 50.7959 16.95%
2013 39.4685 34.5883 43.4345 34.1784 43.4345 26.80%
2012 33.7839 30.7610 39.7384 29.9659 34.2537 13.13%
2011 26.7112 27.6425 30.4398 23.3783 30.2791 9.54%
2010 26.9897 27.2189 30.1754 23.6431 27.6425 2.86%
2009 21.2174 21.6237 27.9470 14.8815 26.8732 26.73%
2008 25.1574 38.3024 40.4254 16.2014 21.2052 -45.34%
2007 33.3223 28.5173 40.5723 27.8176 38.7964 37.36%
2006 24.3288 20.3846 29.6835 20.3846 28.2452 42.66%
2005 18.5596 18.5100 20.9319 15.8845 19.7995 4.04%
2004 24.2974 26.8306 28.0151 15.1872 19.0311 -27.76%
2003 28.8185 30.5800 33.6417 22.9578 26.3459 -11.35%
2002 27.9673 30.5883 33.1320 20.2275 29.7190 -1.26%
2001 35.9270 46.5573 46.5573 29.2626 30.0969 -35.79%
2000 36.6034 33.2768 47.4334 26.6691 46.8727 41.78%
1999 35.7308 36.2885 41.9945 29.7464 33.0603 -7.48%
1998 30.9518 25.6654 38.4445 24.5443 35.7313 41.32%
1997 22.3131 18.7058 25.5938 18.7058 25.2837 35.61%
1996 15.7519 14.7294 19.6301 13.1323 18.6450 23.92%
1995 11.2053 8.5771 15.3323 8.1570 15.0458 76.57%
1994 7.3047 7.6093 8.8006 6.1799 8.5212 14.82%
1993 7.4536 9.1940 9.1940 6.1033 7.4215 -18.35%
1992 10.0619 11.3948 11.5653 8.5709 9.0893 -20.29%
1991 8.1343 6.0116 11.4030 5.5246 11.4030 88.88%
1990 5.2374 5.1494 6.0371 4.4243 6.0371 18.95%
1989 4.5587 3.6601 5.2092 3.6601 5.0754 37.47%
1988 3.4524 3.4170 3.7788 3.0247 3.6921 12.05%
1987 3.4947 2.6193 4.5215 2.6193 3.2950 27.96%
1986 1.9875 1.4344 2.6921 1.4072 2.5751 80.84%
1985 1.1414 0.9680 1.4240 0.9394 1.4240 45.74%
1984 0.9211 0.9394 1.0082 0.8289 0.9771 4.01%
1983 0.9453 0.8731 1.0836 0.8523 0.9394 6.80%
1982 0.7991 0.8887 0.9121 0.6678 0.8796 -0.15%
1981 0.9035 0.8939 1.0642 0.7952 0.8809 0.00%
1980 0.7561 0.7354 0.8809 0.6107 0.8809 17.30%
1979 0.7018 0.7056 0.7678 0.6509 0.7510 6.84%
1978 0.5986 0.5573 0.7186 0.5003 0.7029 21.84%
1977 0.5837 0.6964 0.6964 0.5237 0.5769 -18.53%
1976 0.7434 0.7238 0.8355 0.6548 0.7081 -1.63%
1975 0.7741 0.6990 0.8887 0.6107 0.7198 4.32%
1974 0.7470 0.8355 0.8900 0.5093 0.6900 -17.79%
1973 0.9285 0.9407 1.0446 0.8082 0.8393 -9.39%
1972 0.7939 0.6509 0.9303 0.6509 0.9263 43.75%
1971 0.5509 0.4937 0.6795 0.4937 0.6444 25.25%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $201.378B $40.122B
Merck & Co., Inc., a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Through their prescription medicines, vaccines, biologic therapies and animal health products, they work with customers and operate the countries to deliver innovative health solutions. The Company also demonstrate their commitment to increasing access to health care through far-reaching policies, programs and partnerships. Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $390.684B 18.32
Pfizer (PFE) United States $262.581B 14.80
Novartis AG (NVS) Switzerland $204.469B 17.47
AbbVie (ABBV) United States $134.913B 11.98
Eli Lilly (LLY) United States $119.915B 21.08
Sanofi (SNY) France $111.886B 13.85
Novo Nordisk (NVO) Denmark $108.835B 17.67
AstraZeneca (AZN) United Kingdom $103.621B 12.86
GlaxoSmithKline (GSK) United Kingdom $101.752B 13.68
Bristol-Myers Squibb (BMY) United States $86.262B 14.21